MDX-1-targeting LSP vaccine (Vaxeal)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMDX-1-targeting LSP vaccine (Vaxeal)

Drug Alias NameMDX-1 targeting long synthetic peptide vaccine (Vaxeal)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVaxeal Holding SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxeal Holding SA

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A